ArticleJournal of Cancer2017

The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition.

Luca Mologni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.